FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2116749750> ?p ?o ?g. }

• W2116749750 abstract "Background This is an updated version of a previously published review in The Cochrane Library (2005, Issue 2) on 'Megestrol acetate for the treatment of anorexia‐cachexia syndrome'. Megestrol acetate (MA) is currently used to improve appetite and to increase weight in cancer‐associated anorexia. In 1993, MA was approved by the US Food and Drug Administration for the treatment of anorexia, cachexia or unexplained weight loss in patients with AIDS. The mechanism by which MA increases appetite is unknown and its effectiveness for anorexia and cachexia in neoplastic and AIDS (acquired immunodeficiency syndrome) patients is under investigation. Objectives To evaluate the efficacy, effectiveness and safety of MA in palliating anorexia‐cachexia syndrome in patients with cancer, AIDS and other underlying pathologies. Search methods We sought studies through an extensive search of electronic databases, journals, reference lists, contact with investigators and other search strategies outlined in the methods. The most recent search for this update was carried out in May 2012. Selection criteria Studies were included in the review if they assessed MA compared to placebo or other drug treatments in randomised controlled trials of patients with a clinical diagnosis of anorexia‐cachexia syndrome related to cancer, AIDS or any other underlying pathology. Data collection and analysis Two independent review authors conducted data extraction and evaluated methodological quality. We performed quantitative analyses using appetite and quality of life as a dichotomous variable, and analysed weight gain as continuous and dichotomous variables. Main results We included 35 trials in this update, the same number but not the same trials as in the previous version of the review. The trials comprised 3963 patients for effectiveness and 3180 for safety. Sixteen trials compared MA at different doses with placebo, seven trials compared different doses of MA with other drug treatments and 10 trials compared different doses of MA. Meta‐analysis showed a benefit of MA compared with placebo, particularly with regard to appetite improvement and weight gain in cancer, AIDS and other underlying conditions, and lack of benefit in the same patients when MA was compared to other drugs. There was insufficient information to define the optimal dose of MA, but higher doses were more related to weight improvement than lower doses. Quality of life improvement in patients was seen only when comparing MA versus placebo but not other drugs in both subcategories: cancer and AIDS. Oedema, thromboembolic phenomena and deaths were more frequent in the patients treated with MA. More than 40 side effects were studied. Authors' conclusions This review shows that MA improves appetite and is associated with slight weight gain in cancer, AIDS and in patients with other underlying pathology. Despite the fact that these patients are receiving palliative care they should be informed of the risks involved in taking MA." @default.
• W2116749750 created "2016-06-24" @default.
• W2116749750 creator A5012990947 @default.
• W2116749750 creator A5025085644 @default.
• W2116749750 creator A5027315341 @default.
• W2116749750 creator A5072384122 @default.
• W2116749750 creator A5087068978 @default.
• W2116749750 date "2013-03-28" @default.
• W2116749750 modified "2023-10-15" @default.
• W2116749750 title "Megestrol acetate for treatment of anorexia-cachexia syndrome" @default.
• W2116749750 cites W139851679 @default.
• W2116749750 cites W146491231 @default.
• W2116749750 cites W1480729244 @default.
• W2116749750 cites W1483908846 @default.
• W2116749750 cites W1526732429 @default.
• W2116749750 cites W1527746303 @default.
• W2116749750 cites W1559696051 @default.
• W2116749750 cites W1579350897 @default.
• W2116749750 cites W1580314265 @default.
• W2116749750 cites W173196565 @default.
• W2116749750 cites W173892872 @default.
• W2116749750 cites W1762590985 @default.
• W2116749750 cites W1796184815 @default.
• W2116749750 cites W1801775645 @default.
• W2116749750 cites W1817925071 @default.
• W2116749750 cites W1951350485 @default.
• W2116749750 cites W1964925711 @default.
• W2116749750 cites W1966920013 @default.
• W2116749750 cites W1968272322 @default.
• W2116749750 cites W1968330239 @default.
• W2116749750 cites W1969733974 @default.
• W2116749750 cites W1970861726 @default.
• W2116749750 cites W1974783026 @default.
• W2116749750 cites W1975916174 @default.
• W2116749750 cites W1976861709 @default.
• W2116749750 cites W1976865950 @default.
• W2116749750 cites W1977057354 @default.
• W2116749750 cites W1977169412 @default.
• W2116749750 cites W1979694785 @default.
• W2116749750 cites W1979855377 @default.
• W2116749750 cites W1981079546 @default.
• W2116749750 cites W1982312104 @default.
• W2116749750 cites W1983235754 @default.
• W2116749750 cites W1986215651 @default.
• W2116749750 cites W1988688277 @default.
• W2116749750 cites W1992514303 @default.
• W2116749750 cites W1994836088 @default.
• W2116749750 cites W1997007939 @default.
• W2116749750 cites W2000003362 @default.
• W2116749750 cites W2002689926 @default.
• W2116749750 cites W2004758402 @default.
• W2116749750 cites W2004831401 @default.
• W2116749750 cites W2006627346 @default.
• W2116749750 cites W2007786779 @default.
• W2116749750 cites W2012659096 @default.
• W2116749750 cites W2014913255 @default.
• W2116749750 cites W2016557274 @default.
• W2116749750 cites W2017766892 @default.
• W2116749750 cites W2018034867 @default.
• W2116749750 cites W2019012028 @default.
• W2116749750 cites W2022707678 @default.
• W2116749750 cites W2023043849 @default.
• W2116749750 cites W2023090089 @default.
• W2116749750 cites W2023831021 @default.
• W2116749750 cites W2024701969 @default.
• W2116749750 cites W2027484171 @default.
• W2116749750 cites W2028332009 @default.
• W2116749750 cites W2028426423 @default.
• W2116749750 cites W2029540917 @default.
• W2116749750 cites W2030334683 @default.
• W2116749750 cites W2031632720 @default.
• W2116749750 cites W2034557970 @default.
• W2116749750 cites W2038043146 @default.
• W2116749750 cites W2038563503 @default.
• W2116749750 cites W2038693293 @default.
• W2116749750 cites W2039875234 @default.
• W2116749750 cites W2043759449 @default.
• W2116749750 cites W2047659590 @default.
• W2116749750 cites W2048402210 @default.
• W2116749750 cites W2050638087 @default.
• W2116749750 cites W2051367926 @default.
• W2116749750 cites W2053066924 @default.
• W2116749750 cites W2054909010 @default.
• W2116749750 cites W2056123923 @default.
• W2116749750 cites W2057698211 @default.
• W2116749750 cites W2063738853 @default.
• W2116749750 cites W2077759740 @default.
• W2116749750 cites W2078110114 @default.
• W2116749750 cites W2080633114 @default.
• W2116749750 cites W2080869439 @default.
• W2116749750 cites W2080945325 @default.
• W2116749750 cites W2083081405 @default.
• W2116749750 cites W2083237926 @default.
• W2116749750 cites W2084206690 @default.
• W2116749750 cites W2084880101 @default.
• W2116749750 cites W2091014765 @default.
• W2116749750 cites W2091580529 @default.
• W2116749750 cites W2092404711 @default.
• W2116749750 cites W2094488847 @default.
• W2116749750 cites W2094691909 @default.

• next